Gabapentin Enacarbil Market, Global Outlook and Forecast 2022-2028
Gabapentin enacarbil is an anticonvulsant and analgesic drug of the gabapentinoid class, and a prodrug to gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability, especially when taken with a fatty meal. Gabapentin enacarbil has passed human clinical trials for the treatment of restless legs syndrome, and initial results have shown it to be well tolerated and reasonably effective.
This report contains market size and forecasts of Gabapentin Enacarbil in global, including the following market information:
Global Gabapentin Enacarbil Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gabapentin Enacarbil Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gabapentin Enacarbil companies in 2021 (%)
The global Gabapentin Enacarbil market was valued at 1586.6 million in 2021 and is projected to reach US$ 1783.4 million by 2028, at a CAGR of 1.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gabapentin Enacarbil include Arbor Pharma, Astellas, GlaxoSmithKline, Glenmark Pharma, Pfizer, Depomed, Teva, Mylan and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gabapentin Enacarbil manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gabapentin Enacarbil Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gabapentin Enacarbil Market Segment Percentages, by Type, 2021 (%)
Global Gabapentin Enacarbil Market Segment Percentages, by Application, 2021 (%)
Global Gabapentin Enacarbil Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Gabapentin Enacarbil revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gabapentin Enacarbil revenues share in global market, 2021 (%)
Key companies Gabapentin Enacarbil sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gabapentin Enacarbil sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Gabapentin Enacarbil in global, including the following market information:
Global Gabapentin Enacarbil Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gabapentin Enacarbil Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gabapentin Enacarbil companies in 2021 (%)
The global Gabapentin Enacarbil market was valued at 1586.6 million in 2021 and is projected to reach US$ 1783.4 million by 2028, at a CAGR of 1.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gabapentin Enacarbil include Arbor Pharma, Astellas, GlaxoSmithKline, Glenmark Pharma, Pfizer, Depomed, Teva, Mylan and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gabapentin Enacarbil manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gabapentin Enacarbil Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gabapentin Enacarbil Market Segment Percentages, by Type, 2021 (%)
- Capsule
- Tablet
Global Gabapentin Enacarbil Market Segment Percentages, by Application, 2021 (%)
- Post-Herpetic Neuralgia (PHN)
- Restless Legs Syndrome (RLS)
- Others
Global Gabapentin Enacarbil Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Gabapentin Enacarbil revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gabapentin Enacarbil revenues share in global market, 2021 (%)
Key companies Gabapentin Enacarbil sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gabapentin Enacarbil sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Arbor Pharma
- Astellas
- GlaxoSmithKline
- Glenmark Pharma
- Pfizer
- Depomed
- Teva
- Mylan
- Novartis
- Apotex
- Sun Pharmaceutical
- Aurobindo Pharma
- Intas
- Amneal
- Marksans Pharma
- Alkem
- Jiangsu Enhua
- Jiangsu Hengrui
- Sailike Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Gabapentin Enacarbil Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gabapentin Enacarbil Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GABAPENTIN ENACARBIL OVERALL MARKET SIZE
2.1 Global Gabapentin Enacarbil Market Size: 2021 VS 2028
2.2 Global Gabapentin Enacarbil Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gabapentin Enacarbil Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Gabapentin Enacarbil Players in Global Market
3.2 Top Global Gabapentin Enacarbil Companies Ranked by Revenue
3.3 Global Gabapentin Enacarbil Revenue by Companies
3.4 Global Gabapentin Enacarbil Sales by Companies
3.5 Global Gabapentin Enacarbil Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gabapentin Enacarbil Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gabapentin Enacarbil Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gabapentin Enacarbil Players in Global Market
3.8.1 List of Global Tier 1 Gabapentin Enacarbil Companies
3.8.2 List of Global Tier 2 and Tier 3 Gabapentin Enacarbil Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Gabapentin Enacarbil Market Size Markets, 2021 & 2028
4.1.2 Capsule
4.1.3 Tablet
4.2 By Type - Global Gabapentin Enacarbil Revenue & Forecasts
4.2.1 By Type - Global Gabapentin Enacarbil Revenue, 2017-2022
4.2.2 By Type - Global Gabapentin Enacarbil Revenue, 2023-2028
4.2.3 By Type - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
4.3 By Type - Global Gabapentin Enacarbil Sales & Forecasts
4.3.1 By Type - Global Gabapentin Enacarbil Sales, 2017-2022
4.3.2 By Type - Global Gabapentin Enacarbil Sales, 2023-2028
4.3.3 By Type - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
4.4 By Type - Global Gabapentin Enacarbil Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Gabapentin Enacarbil Market Size, 2021 & 2028
5.1.2 Post-Herpetic Neuralgia (PHN)
5.1.3 Restless Legs Syndrome (RLS)
5.1.4 Others
5.2 By Application - Global Gabapentin Enacarbil Revenue & Forecasts
5.2.1 By Application - Global Gabapentin Enacarbil Revenue, 2017-2022
5.2.2 By Application - Global Gabapentin Enacarbil Revenue, 2023-2028
5.2.3 By Application - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
5.3 By Application - Global Gabapentin Enacarbil Sales & Forecasts
5.3.1 By Application - Global Gabapentin Enacarbil Sales, 2017-2022
5.3.2 By Application - Global Gabapentin Enacarbil Sales, 2023-2028
5.3.3 By Application - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
5.4 By Application - Global Gabapentin Enacarbil Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Gabapentin Enacarbil Market Size, 2021 & 2028
6.2 By Region - Global Gabapentin Enacarbil Revenue & Forecasts
6.2.1 By Region - Global Gabapentin Enacarbil Revenue, 2017-2022
6.2.2 By Region - Global Gabapentin Enacarbil Revenue, 2023-2028
6.2.3 By Region - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
6.3 By Region - Global Gabapentin Enacarbil Sales & Forecasts
6.3.1 By Region - Global Gabapentin Enacarbil Sales, 2017-2022
6.3.2 By Region - Global Gabapentin Enacarbil Sales, 2023-2028
6.3.3 By Region - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gabapentin Enacarbil Revenue, 2017-2028
6.4.2 By Country - North America Gabapentin Enacarbil Sales, 2017-2028
6.4.3 US Gabapentin Enacarbil Market Size, 2017-2028
6.4.4 Canada Gabapentin Enacarbil Market Size, 2017-2028
6.4.5 Mexico Gabapentin Enacarbil Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gabapentin Enacarbil Revenue, 2017-2028
6.5.2 By Country - Europe Gabapentin Enacarbil Sales, 2017-2028
6.5.3 Germany Gabapentin Enacarbil Market Size, 2017-2028
6.5.4 France Gabapentin Enacarbil Market Size, 2017-2028
6.5.5 U.K. Gabapentin Enacarbil Market Size, 2017-2028
6.5.6 Italy Gabapentin Enacarbil Market Size, 2017-2028
6.5.7 Russia Gabapentin Enacarbil Market Size, 2017-2028
6.5.8 Nordic Countries Gabapentin Enacarbil Market Size, 2017-2028
6.5.9 Benelux Gabapentin Enacarbil Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gabapentin Enacarbil Revenue, 2017-2028
6.6.2 By Region - Asia Gabapentin Enacarbil Sales, 2017-2028
6.6.3 China Gabapentin Enacarbil Market Size, 2017-2028
6.6.4 Japan Gabapentin Enacarbil Market Size, 2017-2028
6.6.5 South Korea Gabapentin Enacarbil Market Size, 2017-2028
6.6.6 Southeast Asia Gabapentin Enacarbil Market Size, 2017-2028
6.6.7 India Gabapentin Enacarbil Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gabapentin Enacarbil Revenue, 2017-2028
6.7.2 By Country - South America Gabapentin Enacarbil Sales, 2017-2028
6.7.3 Brazil Gabapentin Enacarbil Market Size, 2017-2028
6.7.4 Argentina Gabapentin Enacarbil Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gabapentin Enacarbil Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gabapentin Enacarbil Sales, 2017-2028
6.8.3 Turkey Gabapentin Enacarbil Market Size, 2017-2028
6.8.4 Israel Gabapentin Enacarbil Market Size, 2017-2028
6.8.5 Saudi Arabia Gabapentin Enacarbil Market Size, 2017-2028
6.8.6 UAE Gabapentin Enacarbil Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Arbor Pharma
7.1.1 Arbor Pharma Corporate Summary
7.1.2 Arbor Pharma Business Overview
7.1.3 Arbor Pharma Gabapentin Enacarbil Major Product Offerings
7.1.4 Arbor Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.1.5 Arbor Pharma Key News
7.2 Astellas
7.2.1 Astellas Corporate Summary
7.2.2 Astellas Business Overview
7.2.3 Astellas Gabapentin Enacarbil Major Product Offerings
7.2.4 Astellas Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.2.5 Astellas Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Gabapentin Enacarbil Major Product Offerings
7.3.4 GlaxoSmithKline Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 Glenmark Pharma
7.4.1 Glenmark Pharma Corporate Summary
7.4.2 Glenmark Pharma Business Overview
7.4.3 Glenmark Pharma Gabapentin Enacarbil Major Product Offerings
7.4.4 Glenmark Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.4.5 Glenmark Pharma Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Gabapentin Enacarbil Major Product Offerings
7.5.4 Pfizer Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Depomed
7.6.1 Depomed Corporate Summary
7.6.2 Depomed Business Overview
7.6.3 Depomed Gabapentin Enacarbil Major Product Offerings
7.6.4 Depomed Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.6.5 Depomed Key News
7.7 Teva
7.7.1 Teva Corporate Summary
7.7.2 Teva Business Overview
7.7.3 Teva Gabapentin Enacarbil Major Product Offerings
7.7.4 Teva Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.7.5 Teva Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Gabapentin Enacarbil Major Product Offerings
7.8.4 Mylan Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.8.5 Mylan Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Gabapentin Enacarbil Major Product Offerings
7.9.4 Novartis Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.9.5 Novartis Key News
7.10 Apotex
7.10.1 Apotex Corporate Summary
7.10.2 Apotex Business Overview
7.10.3 Apotex Gabapentin Enacarbil Major Product Offerings
7.10.4 Apotex Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.10.5 Apotex Key News
7.11 Sun Pharmaceutical
7.11.1 Sun Pharmaceutical Corporate Summary
7.11.2 Sun Pharmaceutical Gabapentin Enacarbil Business Overview
7.11.3 Sun Pharmaceutical Gabapentin Enacarbil Major Product Offerings
7.11.4 Sun Pharmaceutical Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.11.5 Sun Pharmaceutical Key News
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Corporate Summary
7.12.2 Aurobindo Pharma Gabapentin Enacarbil Business Overview
7.12.3 Aurobindo Pharma Gabapentin Enacarbil Major Product Offerings
7.12.4 Aurobindo Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.12.5 Aurobindo Pharma Key News
7.13 Intas
7.13.1 Intas Corporate Summary
7.13.2 Intas Gabapentin Enacarbil Business Overview
7.13.3 Intas Gabapentin Enacarbil Major Product Offerings
7.13.4 Intas Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.13.5 Intas Key News
7.14 Amneal
7.14.1 Amneal Corporate Summary
7.14.2 Amneal Business Overview
7.14.3 Amneal Gabapentin Enacarbil Major Product Offerings
7.14.4 Amneal Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.14.5 Amneal Key News
7.15 Marksans Pharma
7.15.1 Marksans Pharma Corporate Summary
7.15.2 Marksans Pharma Business Overview
7.15.3 Marksans Pharma Gabapentin Enacarbil Major Product Offerings
7.15.4 Marksans Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.15.5 Marksans Pharma Key News
7.16 Alkem
7.16.1 Alkem Corporate Summary
7.16.2 Alkem Business Overview
7.16.3 Alkem Gabapentin Enacarbil Major Product Offerings
7.16.4 Alkem Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.16.5 Alkem Key News
7.17 Jiangsu Enhua
7.17.1 Jiangsu Enhua Corporate Summary
7.17.2 Jiangsu Enhua Business Overview
7.17.3 Jiangsu Enhua Gabapentin Enacarbil Major Product Offerings
7.17.4 Jiangsu Enhua Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.17.5 Jiangsu Enhua Key News
7.18 Jiangsu Hengrui
7.18.1 Jiangsu Hengrui Corporate Summary
7.18.2 Jiangsu Hengrui Business Overview
7.18.3 Jiangsu Hengrui Gabapentin Enacarbil Major Product Offerings
7.18.4 Jiangsu Hengrui Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.18.5 Jiangsu Hengrui Key News
7.19 Sailike Pharma
7.19.1 Sailike Pharma Corporate Summary
7.19.2 Sailike Pharma Business Overview
7.19.3 Sailike Pharma Gabapentin Enacarbil Major Product Offerings
7.19.4 Sailike Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.19.5 Sailike Pharma Key News
8 GLOBAL GABAPENTIN ENACARBIL PRODUCTION CAPACITY, ANALYSIS
8.1 Global Gabapentin Enacarbil Production Capacity, 2017-2028
8.2 Gabapentin Enacarbil Production Capacity of Key Manufacturers in Global Market
8.3 Global Gabapentin Enacarbil Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GABAPENTIN ENACARBIL SUPPLY CHAIN ANALYSIS
10.1 Gabapentin Enacarbil Industry Value Chain
10.2 Gabapentin Enacarbil Upstream Market
10.3 Gabapentin Enacarbil Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gabapentin Enacarbil Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Gabapentin Enacarbil Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gabapentin Enacarbil Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GABAPENTIN ENACARBIL OVERALL MARKET SIZE
2.1 Global Gabapentin Enacarbil Market Size: 2021 VS 2028
2.2 Global Gabapentin Enacarbil Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gabapentin Enacarbil Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Gabapentin Enacarbil Players in Global Market
3.2 Top Global Gabapentin Enacarbil Companies Ranked by Revenue
3.3 Global Gabapentin Enacarbil Revenue by Companies
3.4 Global Gabapentin Enacarbil Sales by Companies
3.5 Global Gabapentin Enacarbil Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gabapentin Enacarbil Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gabapentin Enacarbil Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gabapentin Enacarbil Players in Global Market
3.8.1 List of Global Tier 1 Gabapentin Enacarbil Companies
3.8.2 List of Global Tier 2 and Tier 3 Gabapentin Enacarbil Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Gabapentin Enacarbil Market Size Markets, 2021 & 2028
4.1.2 Capsule
4.1.3 Tablet
4.2 By Type - Global Gabapentin Enacarbil Revenue & Forecasts
4.2.1 By Type - Global Gabapentin Enacarbil Revenue, 2017-2022
4.2.2 By Type - Global Gabapentin Enacarbil Revenue, 2023-2028
4.2.3 By Type - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
4.3 By Type - Global Gabapentin Enacarbil Sales & Forecasts
4.3.1 By Type - Global Gabapentin Enacarbil Sales, 2017-2022
4.3.2 By Type - Global Gabapentin Enacarbil Sales, 2023-2028
4.3.3 By Type - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
4.4 By Type - Global Gabapentin Enacarbil Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Gabapentin Enacarbil Market Size, 2021 & 2028
5.1.2 Post-Herpetic Neuralgia (PHN)
5.1.3 Restless Legs Syndrome (RLS)
5.1.4 Others
5.2 By Application - Global Gabapentin Enacarbil Revenue & Forecasts
5.2.1 By Application - Global Gabapentin Enacarbil Revenue, 2017-2022
5.2.2 By Application - Global Gabapentin Enacarbil Revenue, 2023-2028
5.2.3 By Application - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
5.3 By Application - Global Gabapentin Enacarbil Sales & Forecasts
5.3.1 By Application - Global Gabapentin Enacarbil Sales, 2017-2022
5.3.2 By Application - Global Gabapentin Enacarbil Sales, 2023-2028
5.3.3 By Application - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
5.4 By Application - Global Gabapentin Enacarbil Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Gabapentin Enacarbil Market Size, 2021 & 2028
6.2 By Region - Global Gabapentin Enacarbil Revenue & Forecasts
6.2.1 By Region - Global Gabapentin Enacarbil Revenue, 2017-2022
6.2.2 By Region - Global Gabapentin Enacarbil Revenue, 2023-2028
6.2.3 By Region - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
6.3 By Region - Global Gabapentin Enacarbil Sales & Forecasts
6.3.1 By Region - Global Gabapentin Enacarbil Sales, 2017-2022
6.3.2 By Region - Global Gabapentin Enacarbil Sales, 2023-2028
6.3.3 By Region - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gabapentin Enacarbil Revenue, 2017-2028
6.4.2 By Country - North America Gabapentin Enacarbil Sales, 2017-2028
6.4.3 US Gabapentin Enacarbil Market Size, 2017-2028
6.4.4 Canada Gabapentin Enacarbil Market Size, 2017-2028
6.4.5 Mexico Gabapentin Enacarbil Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gabapentin Enacarbil Revenue, 2017-2028
6.5.2 By Country - Europe Gabapentin Enacarbil Sales, 2017-2028
6.5.3 Germany Gabapentin Enacarbil Market Size, 2017-2028
6.5.4 France Gabapentin Enacarbil Market Size, 2017-2028
6.5.5 U.K. Gabapentin Enacarbil Market Size, 2017-2028
6.5.6 Italy Gabapentin Enacarbil Market Size, 2017-2028
6.5.7 Russia Gabapentin Enacarbil Market Size, 2017-2028
6.5.8 Nordic Countries Gabapentin Enacarbil Market Size, 2017-2028
6.5.9 Benelux Gabapentin Enacarbil Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gabapentin Enacarbil Revenue, 2017-2028
6.6.2 By Region - Asia Gabapentin Enacarbil Sales, 2017-2028
6.6.3 China Gabapentin Enacarbil Market Size, 2017-2028
6.6.4 Japan Gabapentin Enacarbil Market Size, 2017-2028
6.6.5 South Korea Gabapentin Enacarbil Market Size, 2017-2028
6.6.6 Southeast Asia Gabapentin Enacarbil Market Size, 2017-2028
6.6.7 India Gabapentin Enacarbil Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gabapentin Enacarbil Revenue, 2017-2028
6.7.2 By Country - South America Gabapentin Enacarbil Sales, 2017-2028
6.7.3 Brazil Gabapentin Enacarbil Market Size, 2017-2028
6.7.4 Argentina Gabapentin Enacarbil Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gabapentin Enacarbil Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gabapentin Enacarbil Sales, 2017-2028
6.8.3 Turkey Gabapentin Enacarbil Market Size, 2017-2028
6.8.4 Israel Gabapentin Enacarbil Market Size, 2017-2028
6.8.5 Saudi Arabia Gabapentin Enacarbil Market Size, 2017-2028
6.8.6 UAE Gabapentin Enacarbil Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Arbor Pharma
7.1.1 Arbor Pharma Corporate Summary
7.1.2 Arbor Pharma Business Overview
7.1.3 Arbor Pharma Gabapentin Enacarbil Major Product Offerings
7.1.4 Arbor Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.1.5 Arbor Pharma Key News
7.2 Astellas
7.2.1 Astellas Corporate Summary
7.2.2 Astellas Business Overview
7.2.3 Astellas Gabapentin Enacarbil Major Product Offerings
7.2.4 Astellas Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.2.5 Astellas Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Gabapentin Enacarbil Major Product Offerings
7.3.4 GlaxoSmithKline Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 Glenmark Pharma
7.4.1 Glenmark Pharma Corporate Summary
7.4.2 Glenmark Pharma Business Overview
7.4.3 Glenmark Pharma Gabapentin Enacarbil Major Product Offerings
7.4.4 Glenmark Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.4.5 Glenmark Pharma Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Gabapentin Enacarbil Major Product Offerings
7.5.4 Pfizer Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Depomed
7.6.1 Depomed Corporate Summary
7.6.2 Depomed Business Overview
7.6.3 Depomed Gabapentin Enacarbil Major Product Offerings
7.6.4 Depomed Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.6.5 Depomed Key News
7.7 Teva
7.7.1 Teva Corporate Summary
7.7.2 Teva Business Overview
7.7.3 Teva Gabapentin Enacarbil Major Product Offerings
7.7.4 Teva Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.7.5 Teva Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Gabapentin Enacarbil Major Product Offerings
7.8.4 Mylan Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.8.5 Mylan Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Gabapentin Enacarbil Major Product Offerings
7.9.4 Novartis Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.9.5 Novartis Key News
7.10 Apotex
7.10.1 Apotex Corporate Summary
7.10.2 Apotex Business Overview
7.10.3 Apotex Gabapentin Enacarbil Major Product Offerings
7.10.4 Apotex Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.10.5 Apotex Key News
7.11 Sun Pharmaceutical
7.11.1 Sun Pharmaceutical Corporate Summary
7.11.2 Sun Pharmaceutical Gabapentin Enacarbil Business Overview
7.11.3 Sun Pharmaceutical Gabapentin Enacarbil Major Product Offerings
7.11.4 Sun Pharmaceutical Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.11.5 Sun Pharmaceutical Key News
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Corporate Summary
7.12.2 Aurobindo Pharma Gabapentin Enacarbil Business Overview
7.12.3 Aurobindo Pharma Gabapentin Enacarbil Major Product Offerings
7.12.4 Aurobindo Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.12.5 Aurobindo Pharma Key News
7.13 Intas
7.13.1 Intas Corporate Summary
7.13.2 Intas Gabapentin Enacarbil Business Overview
7.13.3 Intas Gabapentin Enacarbil Major Product Offerings
7.13.4 Intas Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.13.5 Intas Key News
7.14 Amneal
7.14.1 Amneal Corporate Summary
7.14.2 Amneal Business Overview
7.14.3 Amneal Gabapentin Enacarbil Major Product Offerings
7.14.4 Amneal Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.14.5 Amneal Key News
7.15 Marksans Pharma
7.15.1 Marksans Pharma Corporate Summary
7.15.2 Marksans Pharma Business Overview
7.15.3 Marksans Pharma Gabapentin Enacarbil Major Product Offerings
7.15.4 Marksans Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.15.5 Marksans Pharma Key News
7.16 Alkem
7.16.1 Alkem Corporate Summary
7.16.2 Alkem Business Overview
7.16.3 Alkem Gabapentin Enacarbil Major Product Offerings
7.16.4 Alkem Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.16.5 Alkem Key News
7.17 Jiangsu Enhua
7.17.1 Jiangsu Enhua Corporate Summary
7.17.2 Jiangsu Enhua Business Overview
7.17.3 Jiangsu Enhua Gabapentin Enacarbil Major Product Offerings
7.17.4 Jiangsu Enhua Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.17.5 Jiangsu Enhua Key News
7.18 Jiangsu Hengrui
7.18.1 Jiangsu Hengrui Corporate Summary
7.18.2 Jiangsu Hengrui Business Overview
7.18.3 Jiangsu Hengrui Gabapentin Enacarbil Major Product Offerings
7.18.4 Jiangsu Hengrui Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.18.5 Jiangsu Hengrui Key News
7.19 Sailike Pharma
7.19.1 Sailike Pharma Corporate Summary
7.19.2 Sailike Pharma Business Overview
7.19.3 Sailike Pharma Gabapentin Enacarbil Major Product Offerings
7.19.4 Sailike Pharma Gabapentin Enacarbil Sales and Revenue in Global (2017-2022)
7.19.5 Sailike Pharma Key News
8 GLOBAL GABAPENTIN ENACARBIL PRODUCTION CAPACITY, ANALYSIS
8.1 Global Gabapentin Enacarbil Production Capacity, 2017-2028
8.2 Gabapentin Enacarbil Production Capacity of Key Manufacturers in Global Market
8.3 Global Gabapentin Enacarbil Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GABAPENTIN ENACARBIL SUPPLY CHAIN ANALYSIS
10.1 Gabapentin Enacarbil Industry Value Chain
10.2 Gabapentin Enacarbil Upstream Market
10.3 Gabapentin Enacarbil Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gabapentin Enacarbil Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Gabapentin Enacarbil in Global Market
Table 2. Top Gabapentin Enacarbil Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gabapentin Enacarbil Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gabapentin Enacarbil Revenue Share by Companies, 2017-2022
Table 5. Global Gabapentin Enacarbil Sales by Companies, (K Units), 2017-2022
Table 6. Global Gabapentin Enacarbil Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gabapentin Enacarbil Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Gabapentin Enacarbil Product Type
Table 9. List of Global Tier 1 Gabapentin Enacarbil Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gabapentin Enacarbil Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gabapentin Enacarbil Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gabapentin Enacarbil Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gabapentin Enacarbil Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gabapentin Enacarbil Sales (K Units), 2017-2022
Table 15. By Type - Global Gabapentin Enacarbil Sales (K Units), 2023-2028
Table 16. By Application – Global Gabapentin Enacarbil Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gabapentin Enacarbil Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gabapentin Enacarbil Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gabapentin Enacarbil Sales (K Units), 2017-2022
Table 20. By Application - Global Gabapentin Enacarbil Sales (K Units), 2023-2028
Table 21. By Region – Global Gabapentin Enacarbil Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gabapentin Enacarbil Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gabapentin Enacarbil Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gabapentin Enacarbil Sales (K Units), 2017-2022
Table 25. By Region - Global Gabapentin Enacarbil Sales (K Units), 2023-2028
Table 26. By Country - North America Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 29. By Country - North America Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 30. By Country - Europe Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 33. By Country - Europe Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 34. By Region - Asia Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 37. By Region - Asia Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 38. By Country - South America Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 41. By Country - South America Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 46. Arbor Pharma Corporate Summary
Table 47. Arbor Pharma Gabapentin Enacarbil Product Offerings
Table 48. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Astellas Corporate Summary
Table 50. Astellas Gabapentin Enacarbil Product Offerings
Table 51. Astellas Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GlaxoSmithKline Corporate Summary
Table 53. GlaxoSmithKline Gabapentin Enacarbil Product Offerings
Table 54. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Glenmark Pharma Corporate Summary
Table 56. Glenmark Pharma Gabapentin Enacarbil Product Offerings
Table 57. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Gabapentin Enacarbil Product Offerings
Table 60. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Depomed Corporate Summary
Table 62. Depomed Gabapentin Enacarbil Product Offerings
Table 63. Depomed Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Teva Corporate Summary
Table 65. Teva Gabapentin Enacarbil Product Offerings
Table 66. Teva Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Mylan Corporate Summary
Table 68. Mylan Gabapentin Enacarbil Product Offerings
Table 69. Mylan Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Novartis Corporate Summary
Table 71. Novartis Gabapentin Enacarbil Product Offerings
Table 72. Novartis Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Apotex Corporate Summary
Table 74. Apotex Gabapentin Enacarbil Product Offerings
Table 75. Apotex Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Sun Pharmaceutical Corporate Summary
Table 77. Sun Pharmaceutical Gabapentin Enacarbil Product Offerings
Table 78. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Aurobindo Pharma Corporate Summary
Table 80. Aurobindo Pharma Gabapentin Enacarbil Product Offerings
Table 81. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Intas Corporate Summary
Table 83. Intas Gabapentin Enacarbil Product Offerings
Table 84. Intas Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Amneal Corporate Summary
Table 86. Amneal Gabapentin Enacarbil Product Offerings
Table 87. Amneal Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Marksans Pharma Corporate Summary
Table 89. Marksans Pharma Gabapentin Enacarbil Product Offerings
Table 90. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Alkem Corporate Summary
Table 92. Alkem Gabapentin Enacarbil Product Offerings
Table 93. Alkem Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Jiangsu Enhua Corporate Summary
Table 95. Jiangsu Enhua Gabapentin Enacarbil Product Offerings
Table 96. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Jiangsu Hengrui Corporate Summary
Table 98. Jiangsu Hengrui Gabapentin Enacarbil Product Offerings
Table 99. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Sailike Pharma Corporate Summary
Table 101. Sailike Pharma Gabapentin Enacarbil Product Offerings
Table 102. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Gabapentin Enacarbil Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Gabapentin Enacarbil Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Gabapentin Enacarbil Production by Region, 2017-2022 (K Units)
Table 106. Global Gabapentin Enacarbil Production by Region, 2023-2028 (K Units)
Table 107. Gabapentin Enacarbil Market Opportunities & Trends in Global Market
Table 108. Gabapentin Enacarbil Market Drivers in Global Market
Table 109. Gabapentin Enacarbil Market Restraints in Global Market
Table 110. Gabapentin Enacarbil Raw Materials
Table 111. Gabapentin Enacarbil Raw Materials Suppliers in Global Market
Table 112. Typical Gabapentin Enacarbil Downstream
Table 113. Gabapentin Enacarbil Downstream Clients in Global Market
Table 114. Gabapentin Enacarbil Distributors and Sales Agents in Global Market
Table 1. Key Players of Gabapentin Enacarbil in Global Market
Table 2. Top Gabapentin Enacarbil Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gabapentin Enacarbil Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gabapentin Enacarbil Revenue Share by Companies, 2017-2022
Table 5. Global Gabapentin Enacarbil Sales by Companies, (K Units), 2017-2022
Table 6. Global Gabapentin Enacarbil Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gabapentin Enacarbil Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Gabapentin Enacarbil Product Type
Table 9. List of Global Tier 1 Gabapentin Enacarbil Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gabapentin Enacarbil Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gabapentin Enacarbil Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gabapentin Enacarbil Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gabapentin Enacarbil Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gabapentin Enacarbil Sales (K Units), 2017-2022
Table 15. By Type - Global Gabapentin Enacarbil Sales (K Units), 2023-2028
Table 16. By Application – Global Gabapentin Enacarbil Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gabapentin Enacarbil Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gabapentin Enacarbil Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gabapentin Enacarbil Sales (K Units), 2017-2022
Table 20. By Application - Global Gabapentin Enacarbil Sales (K Units), 2023-2028
Table 21. By Region – Global Gabapentin Enacarbil Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gabapentin Enacarbil Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gabapentin Enacarbil Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gabapentin Enacarbil Sales (K Units), 2017-2022
Table 25. By Region - Global Gabapentin Enacarbil Sales (K Units), 2023-2028
Table 26. By Country - North America Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 29. By Country - North America Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 30. By Country - Europe Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 33. By Country - Europe Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 34. By Region - Asia Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 37. By Region - Asia Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 38. By Country - South America Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 41. By Country - South America Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gabapentin Enacarbil Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gabapentin Enacarbil Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Gabapentin Enacarbil Sales, (K Units), 2023-2028
Table 46. Arbor Pharma Corporate Summary
Table 47. Arbor Pharma Gabapentin Enacarbil Product Offerings
Table 48. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Astellas Corporate Summary
Table 50. Astellas Gabapentin Enacarbil Product Offerings
Table 51. Astellas Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GlaxoSmithKline Corporate Summary
Table 53. GlaxoSmithKline Gabapentin Enacarbil Product Offerings
Table 54. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Glenmark Pharma Corporate Summary
Table 56. Glenmark Pharma Gabapentin Enacarbil Product Offerings
Table 57. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Gabapentin Enacarbil Product Offerings
Table 60. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Depomed Corporate Summary
Table 62. Depomed Gabapentin Enacarbil Product Offerings
Table 63. Depomed Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Teva Corporate Summary
Table 65. Teva Gabapentin Enacarbil Product Offerings
Table 66. Teva Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Mylan Corporate Summary
Table 68. Mylan Gabapentin Enacarbil Product Offerings
Table 69. Mylan Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Novartis Corporate Summary
Table 71. Novartis Gabapentin Enacarbil Product Offerings
Table 72. Novartis Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Apotex Corporate Summary
Table 74. Apotex Gabapentin Enacarbil Product Offerings
Table 75. Apotex Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Sun Pharmaceutical Corporate Summary
Table 77. Sun Pharmaceutical Gabapentin Enacarbil Product Offerings
Table 78. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Aurobindo Pharma Corporate Summary
Table 80. Aurobindo Pharma Gabapentin Enacarbil Product Offerings
Table 81. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Intas Corporate Summary
Table 83. Intas Gabapentin Enacarbil Product Offerings
Table 84. Intas Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Amneal Corporate Summary
Table 86. Amneal Gabapentin Enacarbil Product Offerings
Table 87. Amneal Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Marksans Pharma Corporate Summary
Table 89. Marksans Pharma Gabapentin Enacarbil Product Offerings
Table 90. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Alkem Corporate Summary
Table 92. Alkem Gabapentin Enacarbil Product Offerings
Table 93. Alkem Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Jiangsu Enhua Corporate Summary
Table 95. Jiangsu Enhua Gabapentin Enacarbil Product Offerings
Table 96. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Jiangsu Hengrui Corporate Summary
Table 98. Jiangsu Hengrui Gabapentin Enacarbil Product Offerings
Table 99. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Sailike Pharma Corporate Summary
Table 101. Sailike Pharma Gabapentin Enacarbil Product Offerings
Table 102. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Gabapentin Enacarbil Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Gabapentin Enacarbil Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Gabapentin Enacarbil Production by Region, 2017-2022 (K Units)
Table 106. Global Gabapentin Enacarbil Production by Region, 2023-2028 (K Units)
Table 107. Gabapentin Enacarbil Market Opportunities & Trends in Global Market
Table 108. Gabapentin Enacarbil Market Drivers in Global Market
Table 109. Gabapentin Enacarbil Market Restraints in Global Market
Table 110. Gabapentin Enacarbil Raw Materials
Table 111. Gabapentin Enacarbil Raw Materials Suppliers in Global Market
Table 112. Typical Gabapentin Enacarbil Downstream
Table 113. Gabapentin Enacarbil Downstream Clients in Global Market
Table 114. Gabapentin Enacarbil Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Gabapentin Enacarbil Segment by Type
Figure 2. Gabapentin Enacarbil Segment by Application
Figure 3. Global Gabapentin Enacarbil Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gabapentin Enacarbil Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gabapentin Enacarbil Revenue, 2017-2028 (US$, Mn)
Figure 7. Gabapentin Enacarbil Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gabapentin Enacarbil Revenue in 2021
Figure 9. By Type - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 10. By Type - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gabapentin Enacarbil Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 13. By Application - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gabapentin Enacarbil Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 16. By Region - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 19. US Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 24. Germany Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 25. France Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 33. China Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 37. India Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 40. Brazil Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 44. Turkey Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gabapentin Enacarbil Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Gabapentin Enacarbil by Region, 2021 VS 2028
Figure 50. Gabapentin Enacarbil Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Gabapentin Enacarbil Segment by Type
Figure 2. Gabapentin Enacarbil Segment by Application
Figure 3. Global Gabapentin Enacarbil Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gabapentin Enacarbil Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gabapentin Enacarbil Revenue, 2017-2028 (US$, Mn)
Figure 7. Gabapentin Enacarbil Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gabapentin Enacarbil Revenue in 2021
Figure 9. By Type - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 10. By Type - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gabapentin Enacarbil Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 13. By Application - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gabapentin Enacarbil Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 16. By Region - Global Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 19. US Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 24. Germany Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 25. France Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 33. China Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 37. India Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 40. Brazil Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gabapentin Enacarbil Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gabapentin Enacarbil Sales Market Share, 2017-2028
Figure 44. Turkey Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gabapentin Enacarbil Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gabapentin Enacarbil Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Gabapentin Enacarbil by Region, 2021 VS 2028
Figure 50. Gabapentin Enacarbil Industry Value Chain
Figure 51. Marketing Channels
